Generic drugs : the pay-for-delay problem

Main
Generic drugs : the pay-for-delay...

Generic drugs : the pay-for-delay problem

Christina M. Curtin, editor.

0 / 0

دا کتاب تاسو ته څنګه خواښه شوه؟

د بار شوي فایل کیفیت څه دئ؟

تر څو چې د کتاب کیفیت آزمایښو وکړئ، بار ئې کړئ

د بار شوو فایلونو کیفیتی څه دئ؟

کال:

2011

خپرندویه اداره:

Nova Biomedical/Nova Science Publishers

ژبه:

english

صفحه:

138

ISBN 10:

1611223601

ISBN 13:

9781611223606

لړ (سلسله):

Public health in the 21st century series.

فایل:

PDF, 3.28 MB

IPFS:

,

english, 2011

په آن لاین ډول لوستل

کاپی کول (pdf, 3.28 MB)

ته بدلون په کار دي

ته بدلون ناکام شو

ممکن تاسی علاقمند شی

Irina Haracoglou — Competition Law and Patents: A Follow-on Innovation Perspective in the Biopharmaceutical Industry (New Horizons in Competition Law and Economics)

Decision Resources Inc — The SAGE Handbook of Healthcare (Sage Handbooks)

Peter Kolchinsky — The Great American Drug Deal

Robinson, Jeffrey, 1945- — Prescription games : money, ego, and power inside the global pharmaceutical industry

Peter Kolchinsky — The Great American Drug Deal

Robin Feldman — Drugs, Money, and Secret Handshakes

Robin Feldman — Drugs, Money, and Secret Handshakes

Schweitzer, Stuart O. & Lu, Z. John — Pharmaceutical Economics and Policy: Perspectives, Promises, and Problems

Herbert Hovenkamp — Tech Monopoly

— Generic Drug Entry Prior To Patent Expiration: An FTC Study

Seget, Steven — Pharmaceutical Pricing Strategies: Price optimization, reimbursement and regulation in Europe, US and Japan

Fathiimage — Article-Innovative Marketing Strategies after Patent Expiry The case of Gsk-s Antibiotic Clamoxyl in France

Schweitzer, Stuart O — Pharmaceutical economics and policy

Christopher R. Leslie — Antitrust Law and Intellectual Property Rights: Cases and Materials

Michael A. Carrier — Innovation for the 21st century : harnessing the power of intellectual property and antitrust law

Ira R. Berry — Introduction to the Pharmaceutical Regulatory Process

Cohen, I. Glenn; Lynch, Holly Fernandez — FDA in the twenty-first century : the challenges of regulating drugs and new technologies

Alan Morrison — Biotechnology Law: A Primer for Scientists

Holly Fernandez Lynch (editor); I. Glenn Cohen (editor) — FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

Alan Morrison — Biotechnology Law: A Primer for Scientists

Herbert Hovenkamp — Tech Monopoly

Christophe S. Harrison — The Politics of the International Pricing of Prescription Drugs

Marcia Angell — The Truth About the Drug Companies: How They Deceive Us and What to Do About It

Marcia Angell — The Truth About the Drug Companies: How They Deceive Us and What to Do About It

Mickey C. Smith (Author) — Pharmaceutical Marketing: Strategy and Cases

Dominique A. Tobbell — Pills, Power, and Policy: The Struggle for Drug Reform in Cold War America and Its Consequences

Dominique A. Tobbell — Pills, Power, and Policy: The Struggle for Drug Reform in Cold War America and Its Consequences

Mark R. Patterson — Antitrust Law in the New Economy: Google, Yelp, LIBOR, and the Control of Information

Casenote Legal Briefs — Casenote Legal Briefs: Antitrust Keyed to Sullivan, Hovencamp & Shelanski’s Antitrust Law, Policy and Procedure, 6th Ed.

Godoy, Angelina Snodgrass — Of Medicines and Markets: Intellectual Property and Human Rights in the Free Trade Era

Godoy, Angelina Snodgrass — Of medicines and markets : intellectual property and human rights in the free trade era

D. Daniel Sokol — The Cambridge Handbook of Antitrust, Intellectual Property, and High Tech

Robin Feldman, Evan Frondorf — Drug Wars: How Big Pharma Raises Prices and Keeps Generics Off the Market

Hans Löfgren (editor) — The Politics of the Pharmaceutical Industry and Access to Medicines: World Pharmacy and India

مهمي جملي